These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34611846)

  • 41. Engineering tolerance using biomaterials to target and control antigen presenting cells.
    Tostanoski LH; Gosselin EA; Jewell CM
    Discov Med; 2016 May; 21(117):403-10. PubMed ID: 27355336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function.
    Zeng H; Yang K; Cloer C; Neale G; Vogel P; Chi H
    Nature; 2013 Jul; 499(7459):485-90. PubMed ID: 23812589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes.
    Samojlik MM; Stabler CL
    Acta Biomater; 2021 Oct; 133():87-101. PubMed ID: 34102338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
    O'Connor G; Krishnan N; Fagan-Murphy A; Cassidy J; O'Leary S; Robertson BD; Keane J; O'Sullivan MP; Cryan SA
    Eur J Pharm Biopharm; 2019 Jan; 134():153-165. PubMed ID: 30385419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
    Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
    Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg.
    Biswas M; Sarkar D; Kumar SR; Nayak S; Rogers GL; Markusic DM; Liao G; Terhorst C; Herzog RW
    Blood; 2015 May; 125(19):2937-47. PubMed ID: 25833958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How GRAIL controls Treg function to maintain self-tolerance.
    Fathman CG; Yip L; Gómez-Martín D; Yu M; Seroogy CM; Hurt CR; Lin JT; Jenks JA; Nadeau KC; Soares L
    Front Immunol; 2022; 13():1046631. PubMed ID: 36569931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunomodulation of antigen presenting cells promotes natural regulatory T cells that prevent autoimmune diabetes in NOD mice.
    Richer MJ; Lavallée DJ; Shanina I; Horwitz MS
    PLoS One; 2012; 7(2):e31153. PubMed ID: 22355341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of Excipients on Stability of Polymer Microparticles for Autoimmune Therapy.
    Gosselin EA; Noshin M; Black SK; Jewell CM
    Front Bioeng Biotechnol; 2020; 8():609577. PubMed ID: 33644005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retinoids differentially regulate the progression of autoimmune diabetes in three preclinical models in mice.
    Stosić-Grujicić S; Cvjetićanin T; Stojanović I
    Mol Immunol; 2009 Nov; 47(1):79-86. PubMed ID: 19211146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
    Turnquist HR; Raimondi G; Zahorchak AF; Fischer RT; Wang Z; Thomson AW
    J Immunol; 2007 Jun; 178(11):7018-31. PubMed ID: 17513751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis.
    Paterka M; Voss JO; Werr J; Reuter E; Franck S; Leuenberger T; Herz J; Radbruch H; Bopp T; Siffrin V; Zipp F
    J Autoimmun; 2017 Jan; 76():108-114. PubMed ID: 27707650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4
    Giang S; Horwitz DA; Bickerton S; La Cava A
    Front Immunol; 2021; 12():628059. PubMed ID: 34122401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FOXP3+ Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children.
    Viisanen T; Gazali AM; Ihantola EL; Ekman I; Näntö-Salonen K; Veijola R; Toppari J; Knip M; Ilonen J; Kinnunen T
    Front Immunol; 2019; 10():19. PubMed ID: 30723474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulatory conversation between antigen presenting cells and regulatory T cells enhance immune suppression.
    Mahnke K; Bedke T; Enk AH
    Cell Immunol; 2007; 250(1-2):1-13. PubMed ID: 18313653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response.
    Kasagi S; Zhang P; Che L; Abbatiello B; Maruyama T; Nakatsukasa H; Zanvit P; Jin W; Konkel JE; Chen W
    Sci Transl Med; 2014 Jun; 6(241):241ra78. PubMed ID: 24944193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of a cocktail regimen consisting of soluble galectin-1, rapamycin and histone deacetylase inhibitor may effectively prevent type 1 diabetes.
    Jiang GX; Cui YF; Zhong XY; Tai S; Liu W; Wang ZD; Shi YG
    Arch Med Res; 2009 Jul; 40(5):424-6. PubMed ID: 19766909
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation.
    Mikami N; Kawakami R; Chen KY; Sugimoto A; Ohkura N; Sakaguchi S
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12258-12268. PubMed ID: 32414925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.